VAL66MET BDNF GENOTYPES IN MELANCHOLIC DEPRESSION: EFFECTS ON BRAIN STRUCTURE AND TREATMENT OUTCOME
- 16 November 2012
- journal article
- research article
- Published by Hindawi Limited in Depression and Anxiety
- Vol. 30 (3) , 225-233
Abstract
Background A brain‐derived neurotrophic factor (BDNF) prodomain single‐nucleotide polymorphism resulting in a valine to methionine substitution (Val66Met) has been associated with depression‐related phenotypes and brain alterations involving regions consistently associated with major depressive disorder (MDD). The aim of our study was to evaluate the association of regional gray matter (GM) volume within the hippocampus and other unpredicted regions at the whole‐brain level with the BDNF Val66Met polymorphism in MDD patients with melancholic features and their impact on treatment outcome. Methods A sample of 37 MDD inpatients was assessed with three‐dimensional magnetic resonance imaging (1.5‐T scanner). GM volume was analyzed with voxel‐based morphometry (VBM) using Statistical Parametric Mapping (SPM5). The BDNF Val66Met variant was genotyped using SNPlex technology. MDD patients were classified according to genotype distribution under a dominant model of inheritance and thus comparing Val66 homozygotes (n = 22) versus Met66 carriers (n = 15). Results A significant GM volume reduction in the left hippocampus was observed in Met66 carriers. Conversely, in the same group, a volume increase in the right orbitofrontal cortex was detected. Moreover, a significant negative correlation between left hippocampal volume and days to remission was found in Val66 homozygotes, whereas right orbitofrontal volume was inversely correlated to days to remission in Met66 carriers. Conclusions Our results suggest that the Val66Met BDNF variant may have a differential impact on the brain structure of melancholic patients with possible treatment outcome implications.Keywords
This publication has 59 references indexed in Scilit:
- No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depressionGenes, Brain and Behavior, 2011
- BDNF Val66met polymorphism, white matter abnormalities and remission of geriatric depressionJournal of Affective Disorders, 2010
- The Brain-Derived Neurotrophic Factor Val66Met Polymorphism, Hippocampal Volume, and Cognitive Function in Geriatric DepressionThe American Journal of Geriatric Psychiatry, 2010
- BDNF Val66Met genotype and 6-month remission rates in late-life depressionThe Pharmacogenomics Journal, 2010
- Type I and Type II error concerns in fMRI research: re-balancing the scaleSocial Cognitive and Affective Neuroscience, 2009
- Imaging phenotypes of major depressive disorder: genetic correlatesNeuroscience, 2009
- Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across developmentNeuroscience, 2009
- Stress-Induced Dendritic Remodeling in the Prefrontal Cortex is Circuit SpecificCerebral Cortex, 2009
- Neurobiological mechanisms in major depressive disorderCanadian Medical Association Journal, 2009
- Brain structural correlates of depressive comorbidity in obsessive–compulsive disorderNeuroImage, 2007